BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Wei J, Wei Y, Cheng L, Guo B, Meng F, Li F, Zhong Z. Apolipoprotein E Peptide-Guided Disulfide-Cross-Linked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma. Biomacromolecules 2020;21:716-24. [DOI: 10.1021/acs.biomac.9b01419] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun Y, Sha Y, Cui G, Meng F, Zhong Z. Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy. Adv Drug Deliv Rev 2023;192:114624. [PMID: 36435229 DOI: 10.1016/j.addr.2022.114624] [Reference Citation Analysis]
2 Liu X, Jiang Z, Xing D, Yang Y, Li Z, Sun Z. Recent progress in nanocomposites of carbon dioxide fixation derived reproducible biomedical polymers. Front Chem 2022;10:1035825. [DOI: 10.3389/fchem.2022.1035825] [Reference Citation Analysis]
3 Li L, Jiang X, Gao J. Characterization and Biomedical Application Opportunities of the Nanoparticle's Protein Corona. Adv Materials Inter. [DOI: 10.1002/admi.202201442] [Reference Citation Analysis]
4 Guo B, Wei J, Wang J, Sun Y, Yuan J, Zhong Z, Meng F. CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy. Acta Biomater 2022;145:200-9. [PMID: 35430336 DOI: 10.1016/j.actbio.2022.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tran HT, Vong LB, Nishikawa Y, Nagasaki Y. Sorafenib-loaded silica-containing redox nanoparticles for oral anti-liver fibrosis therapy. J Control Release 2022:S0168-3659(22)00196-1. [PMID: 35395328 DOI: 10.1016/j.jconrel.2022.04.002] [Reference Citation Analysis]
6 Tian T, Ruan J, Zhang J, Zhao CX, Chen D, Shan J. Nanocarrier-Based Tumor-Targeting Drug Delivery Systems for Hepatocellular Carcinoma Treatments: Enhanced Therapeutic Efficacy and Reduced Drug Toxicity. J Biomed Nanotechnol 2022;18:660-76. [PMID: 35715919 DOI: 10.1166/jbn.2022.3297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Qiu X, Qu Y, Guo B, Zheng H, Meng F, Zhong Z. Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer. J Control Release 2021;341:498-510. [PMID: 34883139 DOI: 10.1016/j.jconrel.2021.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
8 Miao YB, Lin YJ, Chen KH, Luo PK, Chuang SH, Yu YT, Tai HM, Chen CT, Lin KJ, Sung HW. Engineering Nano- and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport. Adv Mater 2021;33:e2104139. [PMID: 34596293 DOI: 10.1002/adma.202104139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Tian X, Gu T, Lee MH, Dong Z. Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer. Biochim Biophys Acta Rev Cancer 2021;1877:188645. [PMID: 34793897 DOI: 10.1016/j.bbcan.2021.188645] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
10 Wei J, Xia Y, Meng F, Ni D, Qiu X, Zhong Z. Small, Smart, and LDLR-Specific Micelles Augment Sorafenib Therapy of Glioblastoma. Biomacromolecules 2021;22:4814-22. [PMID: 34677048 DOI: 10.1021/acs.biomac.1c01103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Iacobazzi RM, Vischio F, Arduino I, Canepa F, Laquintana V, Notarnicola M, Scavo MP, Bianco G, Fanizza E, Lopedota AA, Cutrignelli A, Lopalco A, Azzariti A, Curri ML, Franco M, Giannelli G, Lee BC, Depalo N, Denora N. Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles. J Colloid Interface Sci 2021;608:239-54. [PMID: 34626971 DOI: 10.1016/j.jcis.2021.09.174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kong FH, Ye QF, Miao XY, Liu X, Huang SQ, Xiong L, Wen Y, Zhang ZJ. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma. Theranostics 2021;11:5464-90. [PMID: 33859758 DOI: 10.7150/thno.54822] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
13 Yu W, Maynard E, Chiaradia V, Arno MC, Dove AP. Aliphatic Polycarbonates from Cyclic Carbonate Monomers and Their Application as Biomaterials. Chem Rev 2021;121:10865-907. [DOI: 10.1021/acs.chemrev.0c00883] [Cited by in Crossref: 59] [Cited by in F6Publishing: 74] [Article Influence: 29.5] [Reference Citation Analysis]
14 Kim J, Lee S, Na K. Glycyrrhetinic Acid-Modified Silicon Phthalocyanine for Liver Cancer-Targeted Photodynamic Therapy. Biomacromolecules 2021;22:811-22. [PMID: 33356155 DOI: 10.1021/acs.biomac.0c01550] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]